Home › Companies › ELANCO ANIMAL HEALTH INC. › 2024-2025

ELANCO ANIMAL HEALTH INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and ELANCO ANIMAL HEALTH INC.’s Form 8-K, filed 2025-05-21 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 7Reported items
  • 385Asset managers
  • 2,646Fund votes
  • 2025-05-16Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore ELANCO ANIMAL HEALTH INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by ELANCO ANIMAL HEALTH INC.

These tallies are ELANCO ANIMAL HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-21 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

ELANCO ANIMAL HEALTH INC. — official shareholder meeting results, meeting held 2025-05-16
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Kapila K. Anand 300,900,004156,032,826208,081 --16,176,812 Majority: yes
Elect Director: Paul Herendeen 432,060,24824,992,50488,159 --16,176,812 Majority: yes
Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025, by the votes set forth in the table below. 470,067,1583,077,086173,479 ---- Majority: yes
Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below. 244,532,049212,491,837117,025 --16,176,812 Majority: yes

Source: ELANCO ANIMAL HEALTH INC., Form 8-K, filed with the SEC on 2025-05-21 — read the filing on EDGAR.

How asset managers voted at the ELANCO ANIMAL HEALTH INC. 2024-2025 meeting

Each item below shows how the 385 asset managers that disclosed a ELANCO ANIMAL HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ELANCO ANIMAL HEALTH INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Advisory vote on the compensation of the company's named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 10 wordings of this item as funds reported it.

53.5% Majority: yes · of votes cast

FOR 53.5%AGAINST 46.5%
FOR: 244,532,049AGAINST: 212,491,837

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco's named executive officers, by the votes set forth in the table below.”): 244,532,049 for, 212,491,837 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 496,458,420 outstanding shares: 49.3% for, 43% against (92% of the company cast a for/against vote).

The 378 asset managers below cast 45.9% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 45.9%AGAINST 54.1%
FOR: 45.9%AGAINST: 54.1%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “Advisory vote on the compensation of the company's named executive officers.” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Dodge & Cox0143,523,810 00Against
Vanguard49,185,24337,581,035 00For
Fidelity84,000,4930 00For
PRIMECAP MANAGEMENT CO/CA/047,191,081 00Against
T. Rowe Price22,221,6240 00For
Black Creek Investment Management Inc.21,512,1210 00For
Dimensional019,604,008 00Against
BlackRock18,358,712200,034 00For
Nuveen26,17514,260,161 00Against
SHAPIRO CAPITAL MANAGEMENT LLC10,759,2220 00For
Charles Schwab9,947,3040 00For
John Hancock9,373,649452,355 00For
Prudential/PGIM08,838,745 00Against
GEODE CAPITAL MANAGEMENT, LLC8,218,4220 00For
State Street7,480,1292,196 00For
PRIMECAP Odyssey Funds07,322,594 00Against
TIAA07,193,043 00Against
BARROW HANLEY MEWHINNEY & STRAUSS LLC06,644,355 00Against
Bridge Builder Trust1,486,4035,111,755 00Against
Federated Hermes03,606,075 00Against
BRANDES INVESTMENT PARTNERS, LP03,593,847 00Against
Utah Retirement Systems3,219,8920 00For
Goldman Sachs3,204,7020 00For
Wellington03,096,068 00Against
PRIVATE MANAGEMENT GROUP INC2,534,7320 00For

Showing the 25 largest of 378 asset managers. See all 378 in the interactive database.

2. Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

97% fund support · no official result

ONE YEAR 72%1 YEAR 25%

The 363 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR: 0.0%AGAINST: 0.0%ABSTAIN: 0.0%ONE YEAR: 71.6%1 YEAR: 24.7%THREE YEARS: 3.3%1-YEAR: 0.2%3 YEARS: 0.2%NOT VOTED: 0.0%1-YR: 0.0%2 YEARS: 0.0%3 YEAR: 0.0%1.0: 0.0%3.0: 0.0%2 YEAR: 0.0%2.0: 0.0%
Largest asset managers voting on “Advisory vote on the frequency with which shareholders vote on the compensation of the company's named executi” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Dodge & Cox00 00One Year
Vanguard00 00One Year
Fidelity00 00One Year
PRIMECAP MANAGEMENT CO/CA/00 001 Year
T. Rowe Price00 00One Year
Black Creek Investment Management Inc.00 00One Year
Dimensional00 00Three Years
BlackRock00 001 Year
Nuveen00 00One Year
SHAPIRO CAPITAL MANAGEMENT LLC00 001 Year
Charles Schwab00 001 Year
John Hancock00 00One Year
Prudential/PGIM00 001 Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
State Street00 00One Year
PRIMECAP Odyssey Funds00 001 Year
TIAA00 00One Year
BARROW HANLEY MEWHINNEY & STRAUSS LLC00 001 Year
Bridge Builder Trust00 001 Year
Federated Hermes00 001 Year
BRANDES INVESTMENT PARTNERS, LP00 001 Year
Utah Retirement Systems00 001 Year
Goldman Sachs00 00One Year
Wellington00 001 Year
PRIVATE MANAGEMENT GROUP INC00 001 Year

Showing the 25 largest of 363 asset managers. See all 363 in the interactive database.

3. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 470,067,158AGAINST: 3,077,086

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco's independent registered public accounting firm for 2025, by the votes set forth in the table below.”): 470,067,158 for, 3,077,086 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 496,458,420 outstanding shares: 95% for, 0.7% against (95% of the company cast a for/against vote).

The 82 asset managers below cast 99.9% of the shares they voted on this item FOR (270,974,652 for, 41,692 against).

FOR 99.9%
FOR: 270,974,652 (100.0%)AGAINST: 41,692 (0.0%)ABSTAIN: 3,820 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard85,460,1300 00For
Dodge & Cox64,825,0000 00For
Fidelity41,372,5120 00For
Dimensional17,338,2990 00For
PRIMECAP Odyssey Funds7,322,5940 00For
TIAA7,193,0430 00For
Bridge Builder Trust6,598,1580 00For
BlackRock6,039,2220 00For
T. Rowe Price5,835,1030 00For
Charles Schwab4,681,5060 00For
Prudential/PGIM4,319,5940 00For
Nuveen3,427,6180 00For
John Hancock3,217,6280 00For
First Trust1,808,9040 00For
Federated Hermes1,448,4510 00For
Harbor Funds II1,084,6290 00For
VanEck ETF Trust784,0460 00For
AMERICAN BEACON FUNDS639,0820 00For
Empower583,2230 00For
Goldman Sachs480,3420 00For
Hartford443,4560 00For
Jackson National443,0050 00For
Datum One Series Trust411,0290 00For
Virtus358,6950 00For
MASTER INVESTMENT PORTFOLIO340,8440 00For

Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.

4. ELECTION OF DIRECTOR: KAPILA ANAND

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

66% Majority: yes · of votes cast

FOR 66%AGAINST 34%
FOR: 300,900,004AGAINST: 156,032,826

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Kapila K. Anand”): 300,900,004 for, 156,032,826 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 496,458,420 outstanding shares: 61% for, 31% against (92% of the company cast a for/against vote).

The 81 asset managers below cast 52.8% of the shares they voted on this item FOR (143,149,359 for, 127,850,867 against).

FOR 52.8%AGAINST 47.2%
FOR: 143,149,359 (52.8%)AGAINST: 127,850,867 (47.2%)ABSTAIN: 19,745 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTOR: KAPILA ANAND” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard48,286,38437,173,746 00For
Dodge & Cox064,825,000 00Against
Fidelity41,372,5120 00For
Dimensional017,338,299 00Against
PRIMECAP Odyssey Funds07,322,594 00Against
TIAA7,193,0430 00For
Bridge Builder Trust6,598,1580 00For
BlackRock6,039,2220 00For
T. Rowe Price5,835,1030 00For
Charles Schwab4,681,5060 00For
Prudential/PGIM4,257,29562,299 00For
Nuveen3,427,6180 00For
John Hancock2,765,273452,355 00For
First Trust1,808,9040 00For
Federated Hermes1,448,4510 00For
Harbor Funds II1,084,6290 00For
VanEck ETF Trust784,0460 00For
AMERICAN BEACON FUNDS639,0820 00For
Empower583,2230 00For
Goldman Sachs480,3420 00For
Hartford443,4560 00For
Jackson National349,93293,073 00For
Datum One Series Trust0411,029 00Against
Virtus358,6950 00For
MASTER INVESTMENT PORTFOLIO340,8440 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

5. ELECTION OF DIRECTOR: PAUL HERENDEEN

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 432,060,248AGAINST: 24,992,504

ELANCO ANIMAL HEALTH INC.’s own tally for this item (“Elect Director: Paul Herendeen”): 432,060,248 for, 24,992,504 against, per its Form 8-K filed 2025-05-21 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 496,458,420 outstanding shares: 87% for, 5% against (92% of the company cast a for/against vote).

The 81 asset managers below cast 93% of the shares they voted on this item FOR (252,491,079 for, 18,525,072 against).

FOR 93%
FOR: 252,491,079 (93.2%)AGAINST: 18,525,072 (6.8%)ABSTAIN: 3,820 (0.0%)
Largest asset managers voting on “ELECTION OF DIRECTOR: PAUL HERENDEEN” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard85,460,1273 00For
Dodge & Cox64,825,0000 00For
Fidelity41,372,5120 00For
Dimensional017,338,299 00Against
PRIMECAP Odyssey Funds7,322,5940 00For
TIAA7,193,0430 00For
Bridge Builder Trust6,598,1580 00For
BlackRock6,039,2220 00For
T. Rowe Price5,835,1030 00For
Charles Schwab4,681,5060 00For
Prudential/PGIM4,257,29562,299 00For
Nuveen3,427,6180 00For
John Hancock2,765,273452,355 00For
First Trust1,808,9040 00For
Federated Hermes1,448,4510 00For
Harbor Funds II1,084,6290 00For
VanEck ETF Trust784,0460 00For
AMERICAN BEACON FUNDS639,0820 00For
Empower583,2230 00For
Goldman Sachs480,3420 00For
Hartford443,4560 00For
Jackson National349,93293,073 00For
Datum One Series Trust0411,029 00Against
Virtus358,6950 00For
MASTER INVESTMENT PORTFOLIO340,8440 00For

Showing the 25 largest of 81 asset managers. See all 81 in the interactive database.

6. Advisory Vote on Say on Pay Frequency

SECTION 14A SAY-ON-PAY VOTES

— fund support · no official result

ONE YEAR 100%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ONE YEAR: 1,829,004 (100.0%)
Largest asset managers voting on “Advisory Vote on Say on Pay Frequency” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Redwood Grove Capital, LLC00 00One Year
Empower00 00One Year
JPMorgan00 00One Year
TD Waterhouse Canada Inc.00 00One Year
GuideStone00 00One Year
Desjardins Global Asset Management Inc.00 00One Year
Wilshire Advisors LLC00 00One Year

7. 14A Executive Compensation Vote Frequency

SECTION 14A SAY-ON-PAY VOTES

100% fund support · no official result

1 YEAR 98%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (193 for, 0 against).

FOR: 193 (1.8%)1 YEAR: 10,657 (98.2%)
Largest asset managers voting on “14A Executive Compensation Vote Frequency” at ELANCO ANIMAL HEALTH INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Claret Asset Management Corp00 001 Year
Simplify Exchange Traded Funds1930 00For
Baker Avenue Asset Management, LP00 00--

Largest ELANCO ANIMAL HEALTH INC. shareholders voting in 2024-2025

Ranked by the number of ELANCO ANIMAL HEALTH INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 496,458,420 shares outstanding at the time of that meeting.

Top ELANCO ANIMAL HEALTH INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Dodge & Cox 28.91%
2Vanguard 17.48%
3Fidelity 16.92%
4PRIMECAP MANAGEMENT CO/CA/ 9.51%
5T. Rowe Price 4.48%
6Black Creek Investment Management Inc. 4.33%
7Dimensional 3.95%
8BlackRock 3.74%
9Nuveen 2.88%
10SHAPIRO CAPITAL MANAGEMENT LLC 2.17%

Reported ELANCO ANIMAL HEALTH INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

ELANCO ANIMAL HEALTH INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Dodge & Cox 13.89% 13G
FMR (Fidelity) 10.85% 13F
Vanguard Group 9.73% 13F
PRIMECAP MANAGEMENT CO/CA/ 9.23% 13G
T. Rowe Price Investment Management, Inc. 6.35% 13G
BlackRock 4.78% 13F
Dimensional Fund Advisors 4.12% 13F
Nuveen 2.37% 13F
State Street 1.86% 13F
Goldman Sachs 0.96% 13F

Percentages above are of 496,458,420 shares outstanding, as reported by ELANCO ANIMAL HEALTH INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ELANCO ANIMAL HEALTH INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At ELANCO ANIMAL HEALTH INC.'s shareholder meeting held 2025-05-16, in the 2024-2025 proxy season, 385 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,646 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory vote on the compensation of the company's named executive officers. — FOR was 53.5% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: ELANCO ANIMAL HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-21.

ELANCO ANIMAL HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.